| Name | Title | Contact Details |
|---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Target Health Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Sav-Rx is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
MedAfford Global is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hawaii Primary Care Association is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Honolulu, HI. To find more information about Hawaii Primary Care Association, please visit www.hawaiipca.net